Ion Beam Applications SA (IBAB.BR)

IBAB.BR on Brussels Stock Exchange

14.31EUR
8:56am EDT
Price Change (% chg)

€-0.09 (-0.66%)
Prev Close
€14.40
Open
€14.25
Day's High
€14.40
Day's Low
€14.24
Volume
4,301
Avg. Vol
51,992
52-wk High
€14.79
52-wk Low
€6.00

IBAB.BR

Chart for IBAB.BR

About

Ion Beam Applications SA (IBA) is a Belgium-based company that develops and markets technologies, pharmaceutical products and tailored solutions for the healthcare sector, with emphasis on cancer diagnosis and therapy. IBA is also active in the sterilization and ionization field. The Company operates through two business... (more)

Overall

Beta: 1.32
Market Cap (Mil.): €408.08
Shares Outstanding (Mil.): 28.34
Dividend: --
Yield (%): --

Financials

  IBAB.BR Industry Sector
P/E (TTM): -- 41.07 33.65
EPS (TTM): -0.08 -- --
ROI: 3.92 6.89 17.48
ROE: -2.79 10.69 18.31
Search Stocks

Philips, IBA strike partnership deal for cancer centers

BRUSSELS - Philips and Belgium's Ion Beam Applications announced a partnership on Thursday designed to combine IBA's cancer-therapy technology with Philips' medical imaging systems.

11 Sep 2014

Philips, IBA strike partnership deal for cancer centres

BRUSSELS, Sept 11 - Philips and Belgium's Ion Beam Applications announced a partnership on Thursday designed to combine IBA's cancer-therapy technology with Philips' medical imaging systems.

11 Sep 2014

BRIEF-IBA-Philips partner up to advance diagnosis, treatment of cancer

* And Philips join forces to advance diagnosis and treatment of cancer

11 Sep 2014

IBA keeps outlook despite only slight revenue rise

BRUSSELS, Aug 28 - Belgian cancer diagnosis and therapy company Ion Beam Applications (IBA) maintained its guidance for growth this year despite only a marginal rise in revenue in the first half.

28 Aug 2014

BRIEF-IBA posts first-half net result of 7.4 mln euro

* Operating profits rise 16 pct at IBA as margins approach 10 pct target level

28 Aug 2014

Belgium's IBA gets U.S. approval for compact cancer treatment centres

BRUSSELS, July 16 - Belgian radiotherapy company IBA said on Wednesday it had gained U.S. approval for a key technology, which it said should spur more interest in its newer, compact cancer treatment centres.

16 Jul 2014

BRIEF-Ion beam applications signs contract to install a 70 mev cyclotron in Russia

* IBA signs contract to install a 70 mev cyclotron for to production of radiopharmaceuticals in Russia

02 Jul 2014

BRIEF-IBA selected to install first proton therapy center at UMCG in Netherlands

* Iba sa : iba selected to install first proton therapy center at umcg in netherlands

20 Jun 2014

UPDATE 1-Belgium's IBA keeps guidance in spite of slow start to 2014

BRUSSELS, May 14 - Belgian cancer diagnosis and therapy company Ion Beam Applications maintained its revenue outlook for 2014 on Wednesday even though sales in the first three months came in below target.

14 May 2014

Iba keeps guidance in spite of slow start to 2014

BRUSSELS, May 14 - Belgian cancer diagnosis and therapy company Ion Beam Applications maintained its revenue outlook for 2014 even though sales in the first three months came in below target.

14 May 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks